Stay updated on Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.

Latest updates to the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s footer revision version was updated from v3.5.2 to v3.5.3, reflecting a site/UI content version change rather than a change to the clinical study information.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check54 days agoChange Detected- The site revision label was updated from v3.4.2 to v3.4.3. No study data or page content were changed.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-status notice and the v3.4.1 revision note; study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check90 days agoChange DetectedThe page now displays a government funding notice about potential delays and site operation status, and the revision badge was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

Stay in the know with updates to Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.